Promising survival in patients with high-grade gliomas following therapy with a novel boronated porphyrin
- 1 July 2003
- journal article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 10 (4) , 425-427
- https://doi.org/10.1016/s0967-5868(03)00062-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- An Australian experience with temozolomide for the treatment of recurrent high grade gliomasJournal of Clinical Neuroscience, 2001
- Phase I and Pharmacokinetic Study of Photodynamic Therapy for High-Grade Gliomas Using a Novel Boronated PorphyrinJournal of Clinical Oncology, 2001
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseBritish Journal of Cancer, 2000
- Phase II Study of Combination Taxol and Estramustine Phosphate in the Treatment of Recurrent Glioblastoma MultiformeJournal of Neuro-Oncology, 2000
- Descriptive epidemiology of primary brain and CNS tumors: Results from the Central Brain Tumor Registry of the United States, 1990-1994Neuro-Oncology, 1999
- Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: The past decade and where we are headingNeuro-Oncology, 1999
- Photodynamic therapy of brain tumorsSeminars in Surgical Oncology, 1995
- Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma.Proceedings of the National Academy of Sciences, 1992
- Photodynamic Therapy of Cerebral TumorsNeurosurgery Quarterly, 1991
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryNew England Journal of Medicine, 1980